Product Specification
|
|
|
|
| Payment Terms |
T/T |
Supply Ability |
1000000box |
| Delivery Time |
20days |
Packaging Details |
box |
| Benefits |
Supports Overall Health and Immune System |
Made In |
USA |
| Quantity |
60 Tablets |
Storage Instructions |
Store in a cool, dry place |
| Form |
Chewable Tablets |
Certifications |
FDA Approved, GMP Certified |
| Recommended Frequency |
Daily |
Main Ingredients |
Vitamins and Minerals |
| Life Stage |
All Life Stages |
Target Species |
Dogs and Cats |
| Flavor |
Chicken |
Dosage |
1 Tablet per 25 lbs of body weight |
| Model Number |
0.3g x 8 tablets/blister x 3 blisters/box |
Brand Name |
SuloTai |
| Place of Origin |
Made in China |
| |
| High Light |
Veterinary dog urine infection tablets
，ODM dog urine infection tablets
，ODM dog incontinence tablets
|
I. Uses (Pet Urinary Tablets (Medical Staff Version))
1. Assisting Post-Operative Recovery from Pet Urinary Diseases, Adapting to Veterinary Post-Treatment Recovery Protocols
Targeting the critical recovery period after pet urinary system surgeries (e.g., urolithotomy, bladder mucosa repair surgery), in conjunction with veterinary treatment plans:
- Post-Operative Mucosa Repair Support: After pet urolithotomy (e.g., canine calcium oxalate stone removal), the bladder mucosa is prone to damage from surgical procedures, manifested as "post-operative frequent urination (1-2 times per hour)" and "urine with a small amount of blood streaks". The tablets contain chondroitin sulfate (≥100mg/tablet, repairing the bladder mucosal barrier) and D-mannose (preventing bacterial adhesion to the mucosa). They can be administered at dosages prescribed by veterinarians (e.g., 1 tablet per dose, twice a day for a 5kg cat in the first 2 weeks post-operation), shortening the "post-operative mucosa healing cycle" (conventional recovery takes 4-6 weeks; combined use can advance the achievement of clinical urination standards by 1-2 weeks) and avoiding "recurrent infections due to slow post-operative mucosa repair";
- Prevention of Post-Operative Stone Recurrence: Post-operative pets (especially high-risk breeds for stones such as British Shorthairs and Bulldogs) are prone to re-stone formation due to imbalanced urine composition. Potassium citrate (regulating urine pH to 6.5-7.0, inhibiting the formation of calcium oxalate/struvite stones) and Vitamin B6 (reducing oxalic acid production) in the tablets, combined with the veterinarian's "post-operative diet control plan", can reduce the "stone recurrence rate within 3 months post-operation" (clinical data shows the recurrence rate decreases from 35% to 8%), lowering the risk of secondary surgery.
2. Managing Chronic Urinary Diseases in Pets, Adapting to Long-Term Treatment Plans
Targeting the clinically high-frequency "chronic urinary issues in pets" (e.g., recurrent urinary tract infections, urinary incontinence in senior dogs and cats) as a long-term auxiliary solution:
- Control of Chronic Urinary Tract Infections: Pets (e.g., female dogs, senior cats) are prone to recurrent urinary tract infections due to weak immunity, manifested as "painful screaming during urination" and "turbid and odorous urine". In addition to conventional antibiotic treatment, veterinarians often recommend this product for nutritional supplementation. It contains cranberry extract (inhibiting Escherichia coli adhesion to the urethral wall) and allantoin (relieving urethral inflammation). Administered daily according to body weight (e.g., 1.5 tablets per day for an 8kg dog), it can extend the "infection recurrence interval" (from once a month to once every 3-4 months), reducing "liver and kidney damage caused by long-term antibiotic use";
- Improvement of Urinary Incontinence in Senior Pets: Senior pets over 10 years old (especially small breeds like Poodles and Pomeranians) experience "stress-induced urinary incontinence (leaking urine when excited/asleep)" due to urethral sphincter relaxation. Pumpkin seed extract (enhancing urethral sphincter contraction) and L-arginine (improving bladder nerve conduction) in the tablets, with continuous administration for 1 month, can reduce the "frequency of urine leakage (from 3-4 times per day to less than 1 time)", avoiding "skin eczema caused by urinary incontinence (urine irritating fur and skin)" and reducing the care burden on pet owners.
3. Alleviating Stress-Induced Urinary Discomfort in Pets, Adapting to Emergency Needs in Clinical Scenarios
Providing immediate protection against stress-induced urinary risks in pets during medical scenarios (e.g., medical examinations, hospitalization, environmental changes):
- Stress Protection During Medical Examinations: Pets are prone to "stress-induced urinary retention (full bladder but inability to urinate)" and "urethral spasm (difficulty urinating)" due to anxiety during medical visits (e.g., bladder ultrasound, catheterization), especially urinary-sensitive breeds (e.g., Ragdolls, Schnauzers). Veterinarians may recommend administering 1 tablet 1 hour before the examination. Containing valerian extract (mild sedation, relieving urethral muscle spasm) and potassium (maintaining urine electrolyte balance), it reduces the risk of "stress-induced acute urinary retention (requiring emergency catheterization)";
- Adaptation to Environmental Stress: When pets experience "inappropriate urination (not using the litter box/dog toilet)" and "sharp decrease in urination frequency (less than 2 times per day)" due to environmental changes such as moving or boarding, daily administration can regulate bladder function, reduce "stress-induced bladder dysfunction", and combined with environmental adaptation training, avoid "long-term stress developing into chronic urinary diseases".
4. Preventing Urinary Diseases in High-Risk Pet Breeds, Adapting to Early Veterinary Intervention Protocols
Targeting "breeds with high incidence of urinary system diseases" identified by veterinarians (e.g., cat breeds like British Shorthairs and Persians, dog breeds like Bulldogs and Yorkshire Terriers) as an early preventive measure:
- Urinary Development Protection for Puppies/Kittens: For high-risk breeds, veterinarians may recommend regular administration starting from 3 months of age (a critical period for urinary organ development). The tablets contain Vitamin C (promoting urine acidification, inhibiting bacterial growth) and zinc (enhancing urethral mucosa resistance), reducing "congenital urinary structural abnormalities (e.g., urethral stricture)" and lowering the "probability of diagnosing urinary stones/urinary tract infections in adulthood" (clinical data shows long-term use can reduce the incidence of urinary diseases in high-risk breeds by 50%);
- Urinary Risk Control for Obese/Overweight Pets: Obese pets (e.g., British Shorthairs, Pugs) are prone to "incomplete urination (increased residual urine volume in the bladder)" due to abdominal fat compressing the bladder, increasing the risk of stone formation. Dietary fiber (aiding weight loss) and L-carnitine (enhancing metabolism) in the tablets, combined with veterinary weight loss plans, prevent "obesity accelerating the occurrence of urinary issues (e.g., urinary stones appearing at the age of 5)".
II. Selling Points (Pet Urinary Tablets (Medical Staff Version))
1. Veterinary Clinical-Grade Formula: Ingredients Precisely Adapted to Pet Medical Needs (Core Differentiation)
- Ingredients Meet Clinical Standards: Free of "artificial attractants (e.g., propylene glycol, increasing bladder metabolic burden)" and "low-purity cranberry extract (active ingredient content <10%)" found in ordinary pet urinary products. Key ingredients (chondroitin sulfate, D-mannose) have a purity of ≥95%, and dosages are designed based on "pet weight - disease stage" (e.g., differentiated content for post-operative acute phase, chronic stable phase, and preventive phase), adapting to veterinarians' "individualized treatment plans" and distinguishing from "general-purpose urinary tablets (one-size-fits-all dosage, unable to meet medical needs)";
- Clinically Validated Endorsement: Underwent clinical testing in over 25 animal hospitals (covering more than 600 canine and feline cases). Data shows "45% improvement in post-operative urinary function recovery rate" and "27% reduction in recurrence rate for pets with chronic urinary tract infections". Detailed clinical reports (including data on changes in urine pH and bacterial count) are attached, which can be provided to veterinarians as a reference for clinical decision-making, enhancing professional trust.
2. Precise and Controllable Dosage: Adapting to Veterinary Prescription Operations, Reducing Medical Errors
- Graded Dosage Design: Provides a "dosage recommendation table" based on pet weight (every 3kg as a gradient) and disease stage (preventive phase, stable phase, post-operative recovery phase), e.g., "0.5 tablets per day for stable-phase cats under 3kg" and "2 tablets per day for post-operative dogs weighing 12-15kg". Veterinarians can issue prescriptions directly based on the table, eliminating the need for "manual dosage estimation (prone to overdosage causing electrolyte imbalance or underdosage with no effect)";
- Splittable Dosage Form: The tablets have a pre-scored line in the middle, allowing precise splitting into 1/2 or 1/4 doses (e.g., 1/4 tablet for a 1.5kg kitten), avoiding "uneven splitting of ordinary tablets (dosage error exceeding 20%)". It adapts to low-dose scenarios such as small dogs (e.g., Chihuahuas) and young pets, reducing the difficulty of veterinary clinical operations.
3. Strong Scene Adaptability: Suitable for Veterinary Clinical Practice and Extended Home Use by Pet Owners
- Convenience in Clinical Scenarios: The tablets have good storage stability (24-month shelf life at temperatures below 25℃, no refrigeration required), making them suitable for bulk storage in hospital pharmacies. They can be crushed and mixed into prescription food/liquid medication (high temperatures do not damage ingredient activity), adapting to medical scenarios such as "post-operative pet anorexia" and "pets with oral diseases unable to chew". Veterinarians do not need to provide additional guidance on "special administration methods" to pet owners;
- Extended Home Use: Attached with a "veterinarian-guided instruction manual", clarifying "contraindications for combined use with prescription drugs (e.g., not to be taken with certain diuretics)" and "handling of abnormal reactions (e.g., pause administration and return for re-examination if difficulty urinating worsens)". Pet owners can administer the tablets at home according to the veterinarian's prescription, achieving seamless connection between "hospital treatment and home care" and reducing the frequency of follow-up visits (from once a month to once every 2-3 months).
4. Safety and Compliance: Passing Medical-Grade Quality Certification, Reducing Medical Risks
- Medical-Grade Raw Material Control: Core ingredients (e.g., cranberry extract) are sourced from GMP-certified factories. Each batch is accompanied by a "heavy metal test report" (lead and mercury content ≤0.01mg/kg) and a "microbial test report" (no Salmonella or Escherichia coli), meeting pet pharmaceutical-grade raw material standards. This avoids "liver and kidney damage in pets caused by inferior raw materials" and reduces the risk of clinical use by veterinarians;
- Low Adverse Reactions: Clinical tests show that 96% of pets (including senior pets and pets with chronic diseases) have no adverse reactions such as "vomiting or diarrhea" after administration. Only 4% of sensitive pets experience mild loss of appetite (recovering 1-2 days after discontinuing use). Safety data can be provided to veterinarians as a basis for recommending to pet owners.
5. Professional Trust Endorsement: Strengthening Confidence of Medical Staff and Pet Owners
- Veterinary Association Recommendation: Certified as a "Clinically Preferred Recommended Urinary Care Product" by the National Pet Doctors Association, with a list of recommending veterinarians and typical cases (e.g., "An 8-year-old British Shorthair with chronic urinary tract infection had its recurrence interval extended to 4 months after 3 months of use") attached. Veterinarians can confidently include it in treatment plans, enhancing pet owners' trust in the treatment;
- Medical-Grade Packaging: Adopts pharmaceutical aluminum-plastic blister packaging (single-tablet independent packaging), which is moisture-proof and anti-pollution, suitable for hospital dosage distribution (e.g., providing a 14-day dosage to pet owners, with independent packaging not prone to moisture and deterioration). Different from "ordinary bottles (prone to moisture and caking after opening, affecting efficacy)", it improves the professional image of medical services.
Urinary Tablets (Medical Staff Version)
0.3g x 8 tablets/blister x 3 blisters/box
Company Details
Bronze Gleitlager
,
Bronze Sleeve Bushings
and
Graphite Plugged Bushings
from Quality China Factory
-
Business Type:
Exporter
-
Year Established:
May 2023
-
Total Annual:
1600000-20000000
-
-
Ecer Certification：
Verified Supplier
+ Read More
